Skip to main content
Fig. 5 | Respiratory Research

Fig. 5

From: A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease

Fig. 5

Derived deposition data for percentage emitted dose and regional deposition ratios in the lung by COPD severity (PP analysis set). ∆ LSM difference for severe/very severe vs. moderate COPD (95% CI), CI confidence interval, COPD chronic obstructive pulmonary disease, C/P central to peripheral, LSM least squares mean, O/I outer to inner, PI penetration index, PP per protocol, sC/P standardized central/peripheral, SE standard error

Back to article page